Article
Evaluating the causal relationship of Levo-carnitine and risk of schizophrenia: a bidirectional two-sample mendelian randomization study.
BMC psychiatry - 23 Oct 2024
Qiu Haoyuan, Zhong Zicheng, Wu Tianxing, Hu Haoran, Zhou Meijuan, Feng Zhijun
Abstract excerpt
BACKGROUND: Schizophrenia is a debilitating mental disorder affecting about 1% of the global population, characterized by significant cognitive impairments and a strong hereditary component. Carnitine, particularly Levo-carnitine and its derivatives, plays a crucial role in cellular metabolism and mitochondrial function, with evidence suggesting a link between levo-carnitine deficiency and schizophrenia...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
